{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:38:03Z","timestamp":1792791483483,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Cancer Institute NSW Early Career Fellowship","award":["2017\/ECF004"],"award-info":[{"award-number":["2017\/ECF004"]}],"id":[{"id":"https:\/\/ror.org\/029a54f25","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Health and Medical Research Council of Australia","award":["Grants 1186505 and 2029088"],"award-info":[{"award-number":["Grants 1186505 and 2029088"]}],"id":[{"id":"https:\/\/ror.org\/011kf5r70","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Health and Medical Research Council of Australia","award":["ID400413, ID400281"],"award-info":[{"award-number":["ID400413, ID400281"]}],"id":[{"id":"https:\/\/ror.org\/011kf5r70","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Health and Medical Research Council of Australia","award":["ID400413, ID400281"],"award-info":[{"award-number":["ID400413, ID400281"]}],"id":[{"id":"https:\/\/ror.org\/011kf5r70","id-type":"ROR","asserted-by":"crossref"}]},{"name":"U.S. Army Medical Research and Materiel Command Ovarian Cancer Research Program","award":["Award No. W81XWH-21-1-0401"],"award-info":[{"award-number":["Award No. W81XWH-21-1-0401"]}],"id":[{"id":"https:\/\/ror.org\/03cd02q50","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008018","name":"Victorian Cancer Agency","doi-asserted-by":"publisher","award":["MCRF22018"],"award-info":[{"award-number":["MCRF22018"]}],"id":[{"id":"10.13039\/100008018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000182","name":"U.S. Army Medical Research and Materiel Command","doi-asserted-by":"crossref","award":["DAMD17\u201301\u20131-0729"],"award-info":[{"award-number":["DAMD17\u201301\u20131-0729"]}],"id":[{"id":"10.13039\/100000182","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000951","name":"The Cancer Council Victoria","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000951","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Queensland Cancer Fund"},{"name":"The Cancer Council New South Wales","id":[{"id":"https:\/\/ror.org\/05gsbkp40","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001170","name":"The Cancer Foundation of Western Australia","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001170","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001169","name":"The Cancer Council Tasmania","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001169","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100011928","name":"Ovarian Cancer Australia","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100011928","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Peter MacCallum Cancer Centre Foundation"},{"DOI":"10.13039\/501100000950","name":"The Cancer Council South Australia","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000950","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001102","name":"Cancer Council NSW","doi-asserted-by":"publisher","award":["IG 18-01"],"award-info":[{"award-number":["IG 18-01"]}],"id":[{"id":"10.13039\/501100001102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001102","name":"Cancer Council NSW","doi-asserted-by":"publisher","award":["IG 18-01"],"award-info":[{"award-number":["IG 18-01"]}],"id":[{"id":"10.13039\/501100001102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001102","name":"Cancer Council NSW","doi-asserted-by":"publisher","award":["IG 18-01"],"award-info":[{"award-number":["IG 18-01"]}],"id":[{"id":"10.13039\/501100001102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001102","name":"Cancer Council NSW","doi-asserted-by":"publisher","award":["IG 18-01"],"award-info":[{"award-number":["IG 18-01"]}],"id":[{"id":"10.13039\/501100001102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001102","name":"Cancer Council NSW","doi-asserted-by":"publisher","award":["IG 18-01"],"award-info":[{"award-number":["IG 18-01"]}],"id":[{"id":"10.13039\/501100001102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000947","name":"Australian Cancer Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000947","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001171","name":"Cancer Institute NSW","doi-asserted-by":"publisher","award":["2017\/TPG001, REG171150"],"award-info":[{"award-number":["2017\/TPG001, REG171150"]}],"id":[{"id":"10.13039\/501100001171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001171","name":"Cancer Institute NSW","doi-asserted-by":"publisher","award":["2017\/TPG001, REG171150"],"award-info":[{"award-number":["2017\/TPG001, REG171150"]}],"id":[{"id":"10.13039\/501100001171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001171","name":"Cancer Institute NSW","doi-asserted-by":"publisher","award":["2017\/TPG001, REG171150"],"award-info":[{"award-number":["2017\/TPG001, REG171150"]}],"id":[{"id":"10.13039\/501100001171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001171","name":"Cancer Institute NSW","doi-asserted-by":"publisher","award":["2017\/TPG001, REG171150"],"award-info":[{"award-number":["2017\/TPG001, REG171150"]}],"id":[{"id":"10.13039\/501100001171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008810","name":"NSW Ministry of Health","doi-asserted-by":"publisher","award":["CMP-01"],"award-info":[{"award-number":["CMP-01"]}],"id":[{"id":"10.13039\/501100008810","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008810","name":"NSW Ministry of Health","doi-asserted-by":"publisher","award":["CMP-01"],"award-info":[{"award-number":["CMP-01"]}],"id":[{"id":"10.13039\/501100008810","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001774","name":"University of Sydney","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001774","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001047","name":"Ian Potter Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001047","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Medical Research Futures Fund","award":["MRFF-PD"],"award-info":[{"award-number":["MRFF-PD"]}],"id":[{"id":"https:\/\/ror.org\/0513v5k17","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Medical Research Futures Fund","award":["MRFF-PD"],"award-info":[{"award-number":["MRFF-PD"]}],"id":[{"id":"https:\/\/ror.org\/0513v5k17","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Health and Medical Research Council (NHMRC) of Australia European Union grant","award":["GNT1170739"],"award-info":[{"award-number":["GNT1170739"]}],"id":[{"id":"https:\/\/ror.org\/011kf5r70","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Health and Medical Research Council (NHMRC) of Australia European Union grant","award":["GNT1170739"],"award-info":[{"award-number":["GNT1170739"]}],"id":[{"id":"https:\/\/ror.org\/011kf5r70","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Health and Medical Research Council (NHMRC) of Australia European Union grant","award":["GNT1170739"],"award-info":[{"award-number":["GNT1170739"]}],"id":[{"id":"https:\/\/ror.org\/011kf5r70","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Health and Medical Research Council (NHMRC) of Australia European Union grant","award":["GNT1170739"],"award-info":[{"award-number":["GNT1170739"]}],"id":[{"id":"https:\/\/ror.org\/011kf5r70","id-type":"ROR","asserted-by":"crossref"}]},{"name":"NHMRC Fellowship","award":["GNT1137064"],"award-info":[{"award-number":["GNT1137064"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Precis. Onc."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Improved biomarkers of treatment response are needed for patients with high-grade serous ovarian cancer (HGSC). A challenge is substantial anatomical site-to-site variation in expression. We completed data-independent acquisition\u2013mass spectrometry (DIA-MS) analysis of 404 fresh frozen and 78 formalin-fixed, paraffin-embedded HGSC tissue samples from the ovary (adnexal) and a common secondary site (omentum) in 11 patients. This was compared with mutation testing, gene expression, and whole-genome copy number profiling. Proteins with relatively stable intra- and variable inter-individual expression (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u20091651), included a 52-protein module reflecting interferon-mediated tissue inflammation, indicative of a cGAS-STING pathway cytosolic double-stranded (ds) DNA response. The dsDNA sensing\/inflammation score was higher in the omentum compared with the ovary. Ovarian HGSC samples showed marked inter-individual differences in inflammatory and immune responses to DNA damage. Stable discriminative features of the HGSC proteome, a prerequisite for clinical predictive biomarkers, are detectable in ovary (adnexal) tissue samples.\n                  <\/jats:p>","DOI":"10.1038\/s41698-025-00911-y","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T08:58:21Z","timestamp":1749632301000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Overcoming intra-tumoral heterogeneity for biomarker discovery in the high-grade serous ovarian cancer proteome"],"prefix":"10.1038","volume":"9","author":[{"given":"Srikanth S.","family":"Manda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maiken M.","family":"Espersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Mapagu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Bouantoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Boros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoke-Eng","family":"Chiew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sivatharsny","family":"Srirangan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swetansu","family":"Pattnaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine J.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison H.","family":"Brand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dale W.","family":"Garsed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahwan","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David D. L.","family":"Bowtell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The Australian Ovarian Cancer Study (AOCS) Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Lucas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan","family":"Xavier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadia","family":"Mahboob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Bucio-Noble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett","family":"Tully","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G.","family":"Hains","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip J.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Reddel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"DeFazio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary L.","family":"Balleine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,11]]},"reference":[{"key":"911_CR1","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1093\/jnci\/djy071","volume":"111","author":"LC Peres","year":"2019","unstructured":"Peres, L. C. et al. Invasive epithelial ovarian cancer survival by histotype and disease stage. J. Natl. Cancer Inst. 111, 60\u201368 (2019).","journal-title":"J. Natl. Cancer Inst."},{"key":"911_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2020.102111","volume":"91","author":"D Lorusso","year":"2020","unstructured":"Lorusso, D. et al. Newly diagnosed ovarian cancer: which first-line treatment?. Cancer Treat. Rev. 91, 102111 (2020).","journal-title":"Cancer Treat. Rev."},{"key":"911_CR3","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1056\/NEJMoa1810858","volume":"379","author":"K Moore","year":"2018","unstructured":"Moore, K. et al. Maintenance olaparib in patients with newly diagnosed advanced ovarian cancer. N. Engl. J. Med. 379, 2495\u20132505 (2018).","journal-title":"N. Engl. J. Med."},{"key":"911_CR4","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/nature14410","volume":"521","author":"AM Patch","year":"2015","unstructured":"Patch, A. M. et al. Whole-genome characterization of chemoresistant ovarian cancer. Nature 521, 489\u2013494 (2015).","journal-title":"Nature"},{"key":"911_CR5","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1016\/j.cell.2018.03.073","volume":"173","author":"AW Zhang","year":"2018","unstructured":"Zhang, A. W. et al. Interfaces of malignant and immunologic clonal dynamics in ovarian cancer. Cell 173, 1755\u20131769 e1722 (2018).","journal-title":"Cell"},{"key":"911_CR6","doi-asserted-by":"publisher","first-page":"5037","DOI":"10.1158\/1078-0432.CCR-18-0784","volume":"24","author":"GM Chen","year":"2018","unstructured":"Chen, G. M. et al. Consensus on molecular subtypes of high-grade serous ovarian carcinoma. Clin. Cancer Res. 24, 5037\u20135047 (2018).","journal-title":"Clin. Cancer Res."},{"key":"911_CR7","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/path.4536","volume":"236","author":"HS Leong","year":"2015","unstructured":"Leong, H. S. et al. Efficient molecular subtype classification of high-grade serous ovarian cancer. J. Pathol. 236, 272\u2013277 (2015).","journal-title":"J. Pathol."},{"key":"911_CR8","doi-asserted-by":"publisher","first-page":"5198","DOI":"10.1158\/1078-0432.CCR-08-0196","volume":"14","author":"RW Tothill","year":"2008","unstructured":"Tothill, R. W. et al. Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome. Clin. Cancer Res. 14, 5198\u20135208 (2008).","journal-title":"Clin. Cancer Res."},{"key":"911_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.201900109","volume":"19","author":"B Tully","year":"2019","unstructured":"Tully, B. et al. Addressing the challenges of high-throughput cancer tissue proteomics for clinical application: ProCan. Proteomics 19, e1900109 (2019).","journal-title":"Proteomics"},{"key":"911_CR10","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/bjc.2012.581","volume":"108","author":"R Fisher","year":"2013","unstructured":"Fisher, R., Pusztai, L. & Swanton, C. Cancer heterogeneity: implications for targeted therapeutics. Br. J. Cancer 108, 479\u2013485 (2013).","journal-title":"Br. J. Cancer"},{"key":"911_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara, K. et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat. Commun. 4, 2612 (2013).","journal-title":"Nat. Commun."},{"key":"911_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109412","volume":"36","author":"M Bruand","year":"2021","unstructured":"Bruand, M. et al. Cell-autonomous inflammation of BRCA1-deficient ovarian cancers drives both tumor-intrinsic immunoreactivity and immune resistance via STING. Cell Rep. 36, 109412 (2021).","journal-title":"Cell Rep."},{"key":"911_CR13","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","volume":"37","author":"AM Newman","year":"2019","unstructured":"Newman, A. M. et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat. Biotechnol. 37, 773\u2013782 (2019).","journal-title":"Nat. Biotechnol."},{"key":"911_CR14","doi-asserted-by":"crossref","unstructured":"McDermott, J. E. et al. Proteogenomic characterization of ovarian HGSC implicates mitotic kinases, replication stress in observed chromosomal instability. Cell Rep. Med. 1, 100004 (2020).","DOI":"10.1016\/j.xcrm.2020.100004"},{"key":"911_CR15","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1016\/j.annonc.2020.08.2102","volume":"31","author":"RE Miller","year":"2020","unstructured":"Miller, R. E. et al. ESMO recommendations on predictive biomarker testing for homologous recombination deficiency and PARP inhibitor benefit in ovarian cancer. Ann. Oncol. 31, 1606\u20131622 (2020).","journal-title":"Ann. Oncol."},{"key":"911_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-015-0033-4","volume":"3","author":"AM Marquard","year":"2015","unstructured":"Marquard, A. M. et al. Pan-cancer analysis of genomic scar signatures associated with homologous recombination deficiency suggests novel indications for existing cancer drugs. Biomark. Res 3, 9 (2015).","journal-title":"Biomark. Res"},{"key":"911_CR17","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.cell.2016.05.069","volume":"166","author":"H Zhang","year":"2016","unstructured":"Zhang, H. et al. Integrated proteogenomic characterization of human high-grade serous ovarian cancer. Cell 166, 755\u2013765 (2016).","journal-title":"Cell"},{"key":"911_CR18","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41416-022-01797-4","volume":"127","author":"N Shakfa","year":"2022","unstructured":"Shakfa, N., Li, D., Nersesian, S., Wilson-Sanchez, J. & Koti, M. The STING pathway: therapeutic vulnerabilities in ovarian cancer. Br. J. Cancer 127, 603\u2013611 (2022).","journal-title":"Br. J. Cancer"},{"key":"911_CR19","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1158\/2159-8290.CD-19-0761","volume":"10","author":"J Kwon","year":"2020","unstructured":"Kwon, J. & Bakhoum, S. F. The cytosolic DNA-sensing cGAS-STING pathway in cancer. Cancer Discov. 10, 26\u201339 (2020).","journal-title":"Cancer Discov."},{"key":"911_CR20","doi-asserted-by":"crossref","unstructured":"Vazquez-Garcia, I. et al. Ovarian cancer mutational processes drive site-specific immune evasion. Nature 612, 778\u2013786 (2022).","DOI":"10.1038\/s41586-022-05496-1"},{"key":"911_CR21","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1056\/NEJMoa2112651","volume":"386","author":"P Schmid","year":"2022","unstructured":"Schmid, P. et al. Event-free survival with pembrolizumab in early triple-negative breast cancer. N. Engl. J. Med. 386, 556\u2013567 (2022).","journal-title":"N. Engl. J. Med."},{"key":"911_CR22","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/S1470-2045(21)00216-3","volume":"22","author":"E Pujade-Lauraine","year":"2021","unstructured":"Pujade-Lauraine, E. et al. Avelumab alone or in combination with chemotherapy versus chemotherapy alone in platinum-resistant or platinum-refractory ovarian cancer (JAVELIN Ovarian 200): an open-label, three-arm, randomised, phase 3 study. Lancet Oncol. 22, 1034\u20131046 (2021).","journal-title":"Lancet Oncol."},{"key":"911_CR23","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/S1470-2045(21)00303-X","volume":"22","author":"E Barber","year":"2021","unstructured":"Barber, E. & Matei, D. Immunotherapy in ovarian cancer: we are not there yet. Lancet Oncol. 22, 903\u2013905 (2021).","journal-title":"Lancet Oncol."},{"key":"911_CR24","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nature25432","volume":"553","author":"SF Bakhoum","year":"2018","unstructured":"Bakhoum, S. F. et al. Chromosomal instability drives metastasis through a cytosolic DNA response. Nature 553, 467\u2013472 (2018).","journal-title":"Nature"},{"key":"911_CR25","unstructured":"McCluggage, W. G., Lax, S. F., Soslow, R. A., Malpica, A. & Longacre, T. A. In Female genital tumours [Internet]. Vol. 4 WHO classification of tumours series (ed. WHO Classification of Tumours Editorial Board). (International Agency for Research on Cancer, 2020)."},{"key":"911_CR26","first-page":"399","volume":"18","author":"N Lucas","year":"2019","unstructured":"Lucas, N. et al. Accelerated barocycler lysis and extraction sample preparation for clinical proteomics by mass spectrometry. J. Proteome Res. 18, 399\u2013405 (2019).","journal-title":"J. Proteome Res."},{"key":"911_CR27","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3109\/13506129.2011.597798","volume":"18","author":"M Jullig","year":"2011","unstructured":"Jullig, M. et al. A unique case of neural amyloidoma diagnosed by mass spectrometry of formalin-fixed tissue using a novel preparative technique. Amyloid 18, 147\u2013155 (2011).","journal-title":"Amyloid"},{"key":"911_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17641-3","volume":"11","author":"RC Poulos","year":"2020","unstructured":"Poulos, R. C. et al. Strategies to enable large-scale proteomics for reproducible research. Nat. Commun. 11, 3793 (2020).","journal-title":"Nat. Commun."},{"key":"911_CR29","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41592-019-0638-x","volume":"17","author":"V Demichev","year":"2020","unstructured":"Demichev, V., Messner, C. B., Vernardis, S. I., Lilley, K. S. & Ralser, M. DIA-NN: neural networks and interference correction enable deep proteome coverage in high throughput. Nat. Methods 17, 41\u201344 (2020).","journal-title":"Nat. Methods"},{"key":"911_CR30","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.ccell.2022.06.010","volume":"40","author":"E Goncalves","year":"2022","unstructured":"Goncalves, E. et al. Pan-cancer proteomic map of 949 human cell lines. Cancer Cell 40, 835\u2013849 e838 (2022).","journal-title":"Cancer Cell"},{"key":"911_CR31","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1074\/mcp.M113.031591","volume":"13","author":"J Cox","year":"2014","unstructured":"Cox, J. et al. Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Mol. Cell Proteom. 13, 2513\u20132526 (2014).","journal-title":"Mol. Cell Proteom."},{"key":"911_CR32","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1093\/bioinformatics\/bty790","volume":"35","author":"C Xu","year":"2019","unstructured":"Xu, C. et al. smCounter2: an accurate low-frequency variant caller for targeted sequencing data with unique molecular identifiers. Bioinformatics 35, 1299\u20131309 (2019).","journal-title":"Bioinformatics"},{"key":"911_CR33","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jmoldx.2016.10.002","volume":"19","author":"MM Li","year":"2017","unstructured":"Li, M. M. et al. Standards and guidelines for the interpretation and reporting of sequence variants in cancer: a joint consensus recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists. J. Mol. Diagn. 19, 4\u201323 (2017).","journal-title":"J. Mol. Diagn."},{"key":"911_CR34","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17, 405\u2013424 (2015).","journal-title":"Genet. Med."},{"key":"911_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2009-10-11-r128","volume":"10","author":"T Popova","year":"2009","unstructured":"Popova, T. et al. Genome alteration print (GAP): a tool to visualize and mine complex cancer genomic profiles obtained by SNP arrays. Genome Biol. 10, R128 (2009).","journal-title":"Genome Biol."},{"key":"911_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2011-12-4-r41","volume":"12","author":"CH Mermel","year":"2011","unstructured":"Mermel, C. H. et al. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 12, R41 (2011).","journal-title":"Genome Biol."},{"key":"911_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-014-0475-x","volume":"16","author":"KM Timms","year":"2014","unstructured":"Timms, K. M. et al. Association of BRCA1\/2 defects with genomic scores predictive of DNA damage repair deficiency among breast cancer subtypes. Breast Cancer Res. 16, 475 (2014).","journal-title":"Breast Cancer Res."},{"key":"911_CR38","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1158\/2159-8290.CD-11-0206","volume":"2","author":"NJ Birkbak","year":"2012","unstructured":"Birkbak, N. J. et al. Telomeric allelic imbalance indicates defective DNA repair and sensitivity to DNA-damaging agents. Cancer Discov. 2, 366\u2013375 (2012).","journal-title":"Cancer Discov."},{"key":"911_CR39","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1038\/bjc.2012.451","volume":"107","author":"V Abkevich","year":"2012","unstructured":"Abkevich, V. et al. Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer. Br. J. Cancer 107, 1776\u20131782 (2012).","journal-title":"Br. J. Cancer"},{"key":"911_CR40","doi-asserted-by":"publisher","first-page":"5454","DOI":"10.1158\/0008-5472.CAN-12-1470","volume":"72","author":"T Popova","year":"2012","unstructured":"Popova, T. et al. Ploidy and large-scale genomic instability consistently identify basal-like breast carcinomas with BRCA1\/2 inactivation. Cancer Res. 72, 5454\u20135462 (2012).","journal-title":"Cancer Res."},{"key":"911_CR41","doi-asserted-by":"publisher","first-page":"5411","DOI":"10.1158\/1078-0432.CCR-20-0103","volume":"26","author":"A Talhouk","year":"2020","unstructured":"Talhouk, A. et al. Development and validation of the gene expression predictor of high-grade serous ovarian carcinoma molecular SubTYPE (PrOTYPE). Clin. Cancer Res. 26, 5411\u20135423 (2020).","journal-title":"Clin. Cancer Res."},{"key":"911_CR42","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature08460","volume":"462","author":"DA Barbie","year":"2009","unstructured":"Barbie, D. A. et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature 462, 108\u2013112 (2009).","journal-title":"Nature"},{"key":"911_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S Hanzelmann","year":"2013","unstructured":"Hanzelmann, S., Castelo, R. & Guinney, J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 14, 7 (2013).","journal-title":"BMC Bioinform."},{"key":"911_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder, P. & Horvath, S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinform. 9, 559 (2008).","journal-title":"BMC Bioinform."},{"key":"911_CR45","doi-asserted-by":"publisher","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","volume":"49","author":"D Szklarczyk","year":"2021","unstructured":"Szklarczyk, D. et al. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene\/measurement sets. Nucleic Acids Res. 49, D605\u2013D612 (2021).","journal-title":"Nucleic Acids Res."},{"key":"911_CR46","doi-asserted-by":"publisher","first-page":"D543","DOI":"10.1093\/nar\/gkab1038","volume":"50","author":"Y Perez-Riverol","year":"2022","unstructured":"Perez-Riverol, Y. et al. The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res. 50, D543\u2013D552 (2022).","journal-title":"Nucleic Acids Res."},{"key":"911_CR47","unstructured":"Gene Expression Omnibus (GEO), https:\/\/www.ncbi.nlm.nih.gov\/geo\/ (1999)."},{"key":"911_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-128","volume":"14","author":"EY Chen","year":"2013","unstructured":"Chen, E. Y. et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinform. 14, 128 (2013).","journal-title":"BMC Bioinform."},{"key":"911_CR49","doi-asserted-by":"publisher","first-page":"D687","DOI":"10.1093\/nar\/gkab1028","volume":"50","author":"M Gillespie","year":"2022","unstructured":"Gillespie, M. et al. The reactome pathway knowledgebase 2022. Nucleic Acids Res. 50, D687\u2013D692 (2022).","journal-title":"Nucleic Acids Res."}],"container-title":["npj Precision Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41698-025-00911-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-025-00911-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-025-00911-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T15:06:44Z","timestamp":1749654404000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41698-025-00911-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,11]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["911"],"URL":"https:\/\/doi.org\/10.1038\/s41698-025-00911-y","relation":{},"ISSN":["2397-768X"],"issn-type":[{"value":"2397-768X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,11]]},"assertion":[{"value":"19 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.DeF. and R.L.B. have received research support from Illumina for unrelated work. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"172"}}